Stockreport

AIM ImmunoTech to Attend the 2025 Maxim Growth Summit

AIM ImmunoTech Inc.  (AIM) 
PDF OCALA, Fla., Oct. 20, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced it will participate at the 2025 Maxim [Read more]